Navigation Links
Procter & Gamble and World Vision Equip and Empower Zimbabweans in Fight Against Cholera
Date:2/24/2009

he project will be driven by specially-trained, Zimbabwean volunteers, who will deliver their services and then expand the critically-needed training more broadly to community members. The program design is especially important considering that a large number of health care professionals have left Zimbabwe because of the failed infrastructure and lack of pay.

"With an average of one new cholera case in Zimbabwe per minute, a rapid response is critical and we are very grateful to P&G for this partnership," said Keith Kall, executive director of corporate development for World Vision. "Lives will be saved due to their generosity, and many, many Zimbabweans will be armed with new knowledge to protect themselves and their children in the midst of very high-risk circumstances."

"It's particularly important that during this time of financial crisis we continue to think about those most in need and do what we can to help," said Greg Allgood, PhD, director for the P&G Children's Safe Drinking Water Program, the signature program of P&G's Live, Learn and Thrive(TM) Initiative. "World Vision has a particularly effective plan to help save lives in Zimbabwe and will provide more than 50 days of clean drinking water to a child for every dollar donated."

The cholera epidemic in Zimbabwe, having already claimed more than 3,000 lives and with more than 54,000 reported cases is shifting rapidly to rural areas, World Vision reported in January. Rural areas had previously recorded low cases of the epidemic since the first reported case last August.

About World Vision

World Vision is a Christian relief and development organization dedicated to helping children and their communities worldwide reach their full potential by tackling the causes of poverty. World Vision serves the world's poor regardless of a person's religion, race, ethnicity, or gender. For more information, visit
'/>"/>

SOURCE Procter & Gamble
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Procter & Gamble Announces Organizational Changes
2. Procter & Gamble Reaches Settlement on Patent Infringement Lawsuit
3. Procter & Gambles Live, Learn and Thrive Donates $200,000 to Feeding America in an Effort to Fight Child Hunger in America
4. Wyeth Consumer Healthcare Signs Agreement to Purchase ThermaCare from Procter & Gamble
5. Procter & Gamble Confirms Prior Sales and Earnings Guidance for Fourth Quarter 2007/08
6. Procter & Gamble Announces Board Changes
7. New Water Purification Product from Reliance Products and Procter & Gamble now Available in Retail Stores
8. Procter & Gamble Announces Organizational Changes
9. Procter & Gamble Announces Appointment of Director
10. Procter & Gamble Files Infringement Lawsuit
11. Procter & Gamble Products Help Raise Funds, Awareness in Fight Against Childhood Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... Acara Partners, ... announces the return of its complimentary educational webinar series for the ... leaders creates success for their clients through targeted marketing, sales, digital communications, branding ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... proper reimbursement for radiology services and ADVOCATE is leading the transition. ADVOCATE, the ... coding expertise with their Top 10 Tips for ICD-10. The ten tips are ...
(Date:7/6/2015)... ... , ... Health care systems and genomics projects have generated massive patient data ... use this “Big Data” to improve health and cut costs is now on the ... Sinai Health System in New York City. Physicians will have these new capabilities within ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... received nearly $400,000 in grant funds to support a three-year effort to reduce ... The work will be conducted in partnership with the Morehouse School of Medicine’s ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of us ... 29 million Americans have diabetes, the majority of which are Type 2. However, eight ... more than one in three, have prediabetes (abnormally high blood sugar levels). Without reductions ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2
... same breast cancer treatments as Hispanic and white women ... were more likely to be diagnosed// with later-stage cancer ... ,For the study, lead researcher Wendy ... Cancer Center and colleagues examined 2,140 women participating in ...
... weight loss drugs are really safe, an analysis of previous ... was conducted. What// came to light was the lack of ... ,Two Canadian researchers, Raj Padwal and Sumit Majumdar of ... like sibutramine (Meridia), orlistat (Xenical) and rimonabant (Acomplia) are no ...
... near toxic waste may make you diabetic, says a study ... 1993 and 2000.// ,Type-two diabetes has seen a ... from 1980 to 2002. While scientists scramble to find explanations ... the growing diabetes rate. , ,However, the study by ...
... Carolina State University toxologists and Rice University Chemists// has ... intake speed of nanoparticles through the skin. Vitro experiments ... of the research. These bucky balls contained amino acids. ... with the increasing degree of flexing of the skin. ...
... and Prevention (CDC) Atlanta's Division of Tuberculosis Elimination feel ... and made TB tests mandatory for all foreign-born nationals, ... ,Tuberculosis can only be eradicated if all ... necessary, treated for latent TB infection, they say. ...
... Dentists at the Manchester University have developed a new ... x-rays//. This is done by automatically measuring the width ... ,Professor Keith Horner and Dr Hugh Devlin at ... modeling’ technology that was developed by the Division of ...
Cached Medicine News:Health News:Living Near Toxic Waste May Bring On Diabetes 2Health News:Nanoparticle Uptake Zoom by Repetitive Motion 2Health News:All Foreign-born Nationals In US To Be Tested For TB 2
(Date:7/6/2015)... BOSTON , July 6, 2015 ... Inc. (NASDAQ: ISIS ), announced today that ... Orphan Drug Designation to volanesorsen (ISIS-APOCIII Rx ) ... Syndrome (FCS).  FCS is a rare genetic disease ... of pancreatitis. In a Phase 2 study published ...
(Date:7/5/2015)... 6, 2015 Nihon University is pleased ... on Medical-Engineering Collaboration "Medicine Definitely Jumps Up with ... in Tokyo, Japan . Many ... research will present their achievements and future prospects ... industry produced with 8K technology. (Documentation: ...
(Date:7/3/2015)... 4, 2015 Un fournisseur ... que sont l,hypertension, le diabète et les troubles ... l,intermédiaire de plateformes éducatives gratuites et d,une conférence ... (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ) , ... en ligne , Prendre en charge l,hypertension ...
Breaking Medicine Technology:Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3
... 23, 2007 -,Gentium S.p.A. (NASDAQ: GENT) (the ... will be the subject of a poster,presentation ... being held in,Rio de Janeiro, Brazil from ... 2007, Cinara Echart, Ph.D., Manager of,Biological Research ...
... 24 /CNW/ - The weight loss medication Xenical,(orlistat ... such as blood pressure, glycaemic,control and lipid profile ... and hypertension, according to a study analysis,presented at ... ,This analysis strengthens the wealth of data already ...
Cached Medicine Technology:Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology 2Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 2New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 4New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 5New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 6
Inquire...
Superior imaging through a 410,000 pixel CCD, unseen color replication from a digital signal processor in the scope, and the added benefit of four way tip deflection make the TF410 a superior choice ...
The computer-optimized optical design produces large, brilliant images of high resolution....
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Medicine Products: